C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2004
11/04/2004	WO2004094597A2 Anthozoan fluorescent protein genes
11/04/2004	WO2004094596A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/04/2004	WO2004094592A2 Polymer-conjugated glycosylated neublastin
11/04/2004	WO2004094590A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/04/2004	WO2004094589A2 Secreted proteins
11/04/2004	WO2004094472A2 Collagen fibrils carrying bioactive heterologous domains and their use in e.g. wound healing
11/04/2004	WO2004094471A2 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
11/04/2004	WO2004094470A1 Analysis and use of par 1 polymorphisms for the risk estimation of cardiovascular diseases
11/04/2004	WO2004094469A1 Tuberculosis vaccine with improved efficacy
11/04/2004	WO2004094468A2 Method for identifying an anti-streptococcal agent and its use for treating streptococcal infections
11/04/2004	WO2004094467A2 H. pylori antigens
11/04/2004	WO2004094466A2 Recombinant influenza viruses holding a mutation in a transmembrane protein gene
11/04/2004	WO2004094465A2 Synthetic molecules that mimic chemokines
11/04/2004	WO2004094463A2 Peptide inhibitors of autophosphorylation protein kinases
11/04/2004	WO2004094462A2 Methods of peptide preparation
11/04/2004	WO2004094461A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
11/04/2004	WO2004094455A2 Prophylactic and therapeutic benefits of new class of immune stimulating peptides
11/04/2004	WO2004093907A2 Therapeutic agents for treating dermatitis, alopecia and itching and transgenic animals for evaluating such therapeutic agents
11/04/2004	WO2004093905A1 Human cytomegalovirus antigens expressed in mva and methods of use
11/04/2004	WO2004093903A2 Methods and compositions for immunomodulation using cd1 antigens
11/04/2004	WO2004093902A1 CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH α-HELIX STABILIZERS
11/04/2004	WO2004093898A2 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same
11/04/2004	WO2004093892A2 Stanniocalcin-1, variant or antagonists thereof for selective modulation of vascularization
11/04/2004	WO2004093830A2 Model for neurodegenerative disorders
11/04/2004	WO2004093825A2 Methods for obtaining colonization factors from bacterial strains
11/04/2004	WO2004093823A2 Polyethelene glycol link glp-1 compounds
11/04/2004	WO2004093820A2 Methods and compositions for solid tumor treatment
11/04/2004	WO2004093810A2 Methods and compositions for treating disorders
11/04/2004	WO2004093808A2 Novel tumor-associated antigens
11/04/2004	WO2004093807A2 Somatostatin vectors
11/04/2004	WO2004093804A2 Human polypeptides encoded by polynucleotides and methods of their use
11/04/2004	WO2004093790A2 Yeast ectopically expressing abnormally processed proteins and uses therefor
11/04/2004	WO2004093788A2 Desmoglein 4 is a novel gene involved in hair growth
11/04/2004	WO2004093787A2 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms
11/04/2004	WO2004093785A2 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof
11/04/2004	WO2004093782A2 Tumor cytotoxicity induced by modulators of the cxcr4 receptor
11/04/2004	WO2004093662A2 Method for detecting prognosis of cancer
11/04/2004	WO2004093566A2 Functional animal muscle protein concentrate composition and process
11/04/2004	WO2004093532A2 Generation of plants with altered oil content
11/04/2004	WO2004093531A2 Generation of plants with altered oil content
11/04/2004	WO2004093530A2 Generation of plants with altered oil content
11/04/2004	WO2004093529A2 Generation of plants with altered oil content
11/04/2004	WO2004093528A2 Generation of plants with altered oil content
11/04/2004	WO2004086039A8 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof
11/04/2004	WO2004085471A3 Glp-2 derivatives
11/04/2004	WO2004083372A3 Modulators of the notch signaling pathway immobilized on particles for modifying immune responses
11/04/2004	WO2004083245A3 Agent comprise an albumin-like first polypeptide bound to a second polypeptide
11/04/2004	WO2004083244A3 Specific inhibition of allograft rejection
11/04/2004	WO2004081167A3 Expression vectors comprising the mcmv ie2 promoter
11/04/2004	WO2004075912B1 Use of pgrp, lrrp and ctl proteins to trigger an anti-plasmodium immune response in anopheles species
11/04/2004	WO2004065555A3 Regulator/promoter for tunable gene expression and metabolite sensing
11/04/2004	WO2004064713A3 The use of yop preoteins or rho gtpase inhibitors as caspase-1 inhibitors
11/04/2004	WO2004062584A3 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
11/04/2004	WO2004061080A3 Stress-related polypeptides and uses therefor
11/04/2004	WO2004061077A3 Increasing gamete production with a gene switch
11/04/2004	WO2004058996A3 Method for controlling processes based on microbial interaction
11/04/2004	WO2004058805A3 T cell activating gene
11/04/2004	WO2004053077A3 Compositions,splice variants and methods relating to breast specific genes and proteins
11/04/2004	WO2004053075A3 Compositions, splice variants and methods relating to breast specific genes and proteins
11/04/2004	WO2004052925A3 Actinobacillus pleuropneumoniae virulence genes
11/04/2004	WO2004050883A3 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis b core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine
11/04/2004	WO2004048575A3 Streptococcus pneumoniae surface polypeptides
11/04/2004	WO2004047514A3 Methods for identifying risk of breast cancer and treatments thereof
11/04/2004	WO2004044838A3 Computer system and methods for producing morphogen analogs of human tdf-1
11/04/2004	WO2004043340A3 Alpha 5 beta 1 and its ability to regulate the cell survival pathway
11/04/2004	WO2004037797A3 2 - alkyl - (2 - amino - 3 - aryl - propionyl) - piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity
11/04/2004	WO2004035798A3 Identification of e2f target genes and uses thereof
11/04/2004	WO2004035008A3 Treatment of infections and other disorders
11/04/2004	WO2004035007A3 Transmucosal administration of aggregated antigens
11/04/2004	WO2004034029A3 Screening systems and methods for identifying modulators of xenobiotic metabolism
11/04/2004	WO2004033706A3 Nucleic acids encoding duramycin
11/04/2004	WO2004033647A3 Assay methods for state-dependent calcium channel agonists/antagonists
11/04/2004	WO2004024173A3 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism
11/04/2004	WO2004024069A9 Novel compositions and methods for the treatment of immune-related diseases
11/04/2004	WO2004022003A3 Materials and methods for treatment of allergic diseases
11/04/2004	WO2004020454A3 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
11/04/2004	WO2004011484A3 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
11/04/2004	WO2004009618A3 Recombinant production of mixtures of antibodies
11/04/2004	WO2004004652A3 Mitotic kinesin binding site
11/04/2004	WO2004002223A3 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
11/04/2004	WO2003103662A3 Inhibitors of glycoprotein vi
11/04/2004	WO2003091403A3 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases
11/04/2004	WO2003069984A9 Transgenic production in saliva
11/04/2004	WO2003062270A8 Fluorescent protein from aequorea coerulscens and uses therof
11/04/2004	WO2003060091A3 Selective melanin-concentrating hormone type -1 receptor agonists
11/04/2004	WO2003042370A3 New gene expressed in prostate cancer and methods of use
11/04/2004	WO2003030828A3 Nociceptin-based analgesics
11/04/2004	WO2003029420A3 Apo-2 ligand variants and uses thereof
11/04/2004	WO2003021226A3 Peptide biomarker and method of identification
11/04/2004	WO2002086070A3 Binding molecules for fc-region polypeptides
11/04/2004	WO2002081645A3 Cp27 peptides and their use in modulating cell growth and apoptosis
11/04/2004	WO2002072030A8 High affinity integrin polypeptides and uses thereof
11/04/2004	US20040221336 Plants which synthesize a modified starch, process for the production thereof and modified starch
11/04/2004	US20040221334 Immunoglobulin for use in detection of modified insecticidal protein; immunodiagnostics and heterologous gene expression; tissue engineering and biological pest control
11/04/2004	US20040221333 Transgenic plants comprising nucleotide sequences coding insectcidal proteins for use in propagation insect resistant crop plants; tissue engineering and biological pest control
11/04/2004	US20040221332 Plant growth regulating genes, proteins and uses thereof
11/04/2004	US20040221331 Male tissue-preferred regulatory sequences of Ms45 gene and method of using same
11/04/2004	US20040221330 Preparing genetically engineered plant comprising vector with modified upstream regulatory sequences for use as tool in heterologous gene expression in plants; bioreactors; tissue engineering
11/04/2004	US20040221326 Transgenic animal model of bone mass modulation
11/04/2004	US20040220396 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same

1 ... 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 ... 2916